Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BeOne Medicines (BEIGF) EBT Margin (2016 - 2025)

BeOne Medicines (BEIGF) has disclosed EBT Margin for 11 consecutive years, with 9.96% as the latest value for Q4 2025.

  • Quarterly EBT Margin rose 1753.0% to 9.96% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 7.8% through Dec 2025, up 2179.0% year-over-year, with the annual reading at 7.8% for FY2025, 2179.0% up from the prior year.
  • EBT Margin for Q4 2025 was 9.96% at BeOne Medicines, down from 10.42% in the prior quarter.
  • The five-year high for EBT Margin was 29.35% in Q3 2023, with the low at 320.4% in Q2 2021.
  • Average EBT Margin over 5 years is 77.68%, with a median of 43.84% recorded in 2023.
  • The sharpest move saw EBT Margin surged 70824bps in 2021, then crashed -14759bps in 2022.
  • Over 5 years, EBT Margin stood at 283.22% in 2021, then surged by 60bps to 113.38% in 2022, then surged by 51bps to 55.29% in 2023, then surged by 86bps to 7.57% in 2024, then soared by 232bps to 9.96% in 2025.
  • According to Business Quant data, EBT Margin over the past three periods came in at 9.96%, 10.42%, and 7.57% for Q4 2025, Q3 2025, and Q2 2025 respectively.